Literature DB >> 3280494

Compliance and chronic disease.

P S German1.   

Abstract

The shifting demographics of the population and increasing skill in treatment of chronic disease in this country have combined to make compliance a topic of greater salience than ever before. General issues of compliance are a necessary background to specific issues of compliance with regimens for single diseases such as hypertension. The definition of compliance continues to be modified, and examination of past work reveals certain consistencies in studies of compliance. Non-compliance is higher in chronic conditions, in activities requiring change in life-style, and in clinician-initiated visits. Noncomprehension of instructions is held to be the most frequent cause of noncompliance. Noncompliance is a threat to the course of treatment, increases unnecessary diagnostic procedures, and confounds evaluation of effectiveness. Factors related to compliance have been identified with regard to certain patient and disease characteristics, amount of support in the immediate environment, and the nature of the doctor-patient relationship. Older patients are often at greater risk in understanding regimens because clinicians educate this group less often, because symptoms are misunderstood by both patient and provider, and because of greater complexity in both conditions that are being treated and number of drugs and other aspects of treatment required. Methods of improving the doctor-patient relationship have been urged most recently as a means through which compliance can be increased.

Entities:  

Mesh:

Year:  1988        PMID: 3280494     DOI: 10.1161/01.hyp.11.3_pt_2.ii56

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  8 in total

1.  Individualized stepped care of chronic illness.

Authors:  M Von Korff; B Tiemens
Journal:  West J Med       Date:  2000-02

2.  The use of nurses to evaluate houseofficers' humanistic behavior.

Authors:  C B Kaplan; R M Centor
Journal:  J Gen Intern Med       Date:  1990 Sep-Oct       Impact factor: 5.128

Review 3.  A new taxonomy for describing and defining adherence to medications.

Authors:  Bernard Vrijens; Sabina De Geest; Dyfrig A Hughes; Kardas Przemyslaw; Jenny Demonceau; Todd Ruppar; Fabienne Dobbels; Emily Fargher; Valerie Morrison; Pawel Lewek; Michal Matyjaszczyk; Comfort Mshelia; Wendy Clyne; Jeffrey K Aronson; J Urquhart
Journal:  Br J Clin Pharmacol       Date:  2012-05       Impact factor: 4.335

4.  Brief provider communication skills training fails to impact patient hypertension outcomes.

Authors:  Meredith G Manze; Michelle B Orner; Mark Glickman; Lori Pbert; Dan Berlowitz; Nancy R Kressin
Journal:  Patient Educ Couns       Date:  2014-10-27

5.  Discontinuation and switching of therapy after initiation of lipid-lowering drugs: the effects of comorbidities and patient characteristics.

Authors:  Chen-Chang Yang; Susan S Jick; Marcia A Testa
Journal:  Br J Clin Pharmacol       Date:  2003-07       Impact factor: 4.335

6.  Specialty care use in US patients with chronic diseases.

Authors:  Jessica D Bellinger; Rahnuma M Hassan; Patrick A Rivers; Qiang Cheng; Edith Williams; Saundra H Glover
Journal:  Int J Environ Res Public Health       Date:  2010-03-10       Impact factor: 3.390

7.  The determinants of hypertension awareness, treatment, and control in an insured population.

Authors:  D H Stockwell; S Madhavan; H Cohen; G Gibson; M H Alderman
Journal:  Am J Public Health       Date:  1994-11       Impact factor: 9.308

8.  Interventions for body weight reduction in obese patients during short consultations: an open-label randomized controlled trial in the Japanese primary care setting.

Authors:  Satoshi Kanke; Takumi Kawai; Naomi Takasawa; Yukiko Mashiyama; Atsushi Ishii; Ryuki Kassai
Journal:  Asia Pac Fam Med       Date:  2015-05-21
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.